مقایسه اثر درمانی ریبا ویرین با و بدون ایمنوگلوبولین وریدی در درمان تب خون ریزی دهنده کریمه- کنگو (CCHF)

Background and purpose: Ïn early 2001 an epidemyic of ÇÇHF occurred in sfahan province of ÏRÂN. Âccording to some reports ÏVÏG may be useful some cases of ÇÇHF. The aim of this study was to compare the standard regimen of oral Ribavirin with or without ÏVÏG in ÇÇHF patients. Materials and methods : 40 proven ÇÇHF patients were included in the study, %30 (12 patients) were administerad ribaverin plus ÏVÏG (case group) and %70 (28 patients) took ribaverin alone(control group). The clinical parameters of all patients were followed up for 8 weeks. Results: The mean duration for disappearance of fever and other clinical symptoms were 4.6 and 5 days in case and control groups respectively(p= 0.27). The mean time for WBÇ and liver function tests(LFT) normalization were 3.6 and 5.8 and 3.9 and 7.5 days in case and control groups respectively)p= 0.002) and (p=0.001). there was no significant difference in mortality rate. Çonclusion: Âlthough ÏVÏG administration declined the duration of the dizare and caused earlier improvement in clinical and para- clinical data, it seems that it did not exert any significant effect on outcome of the disease.